key: cord-0919126-o4vbb5rp authors: Hoffmann, David; Mereiter, Stefan; Oh, Yoo Jin; Monteil, Vanessa; Zhu, Rong; Canena, Daniel; Hain, Lisa; Laurent, Elisabeth; Grünwald-Gruber, Clemens; Novatchkova, Maria; Ticevic, Melita; Chabloz, Antoine; Wirnsberger, Gerald; Hagelkruys, Astrid; Altmann, Friedrich; Mach, Lukas; Stadlmann, Johannes; Oostenbrink, Chris; Mirazimi, Ali; Hinterdorfer, Peter; Penninger, Josef M. title: Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites date: 2021-04-01 journal: bioRxiv DOI: 10.1101/2021.04.01.438087 sha: 7bfc1e80c44c3ede52bfd82d83342cf402e4fa65 doc_id: 919126 cord_uid: o4vbb5rp New SARS-CoV-2 variants are continuously emerging with critical implications for therapies or vaccinations. All 22 N-glycan sites of SARS-CoV-2 Spike remain highly conserved among the variants B.1.1.7, 501Y.V2 and P.1, opening an avenue for robust therapeutic intervention. Here we used a comprehensive library of mammalian carbohydrate-binding proteins (lectins) to probe critical sugar residues on the full-length trimeric Spike and the receptor binding domain (RBD) of SARS-CoV-2. Two lectins, Clec4g and CD209c, were identified to strongly bind to Spike. Clec4g and CD209c binding to Spike was dissected and visualized in real time and at single molecule resolution using atomic force microscopy. 3D modelling showed that both lectins can bind to a glycan within the RBD-ACE2 interface and thus interferes with Spike binding to cell surfaces. Importantly, Clec4g and CD209c significantly reduced SARS-CoV-2 infections. These data report the first extensive map and 3D structural modelling of lectin-Spike interactions and uncovers candidate receptors involved in Spike binding and SARS-CoV-2 infections. The capacity of CLEC4G and mCD209c lectins to block SARS-CoV-2 viral entry holds promise for pan-variant therapeutic interventions. N331 and N343 between Spike and RBD (Fig. 1C) . This highlights the importance of 126 using a full-length trimeric Spike protein for functional studies. To confirm that the 127 observed interactions were independent of protein conformation, Spike was denatured 128 prior to the ELISA assay; binding of CD209c and Clec4g to the unfolded Spike 129 remained unaltered (Fig. 2C) . Importantly, enzymatic removal of N-glycans by 130 PNGase F treatment reduced the binding of CD209c, Clec4g, and Mgl2 towards Spike 131 To study Spike binding of these two lectins at the single-molecule level, we used 149 atomic force microscopy (AFM) and performed single molecule force spectroscopy 150 to its receptor ACE2. hCD209 is known to bind with high affinity to oligo-mannose 200 structures (Guo et al., 2004) . The N234 glycosylation site is the only site within the 201 Spike that carries exclusively oligo-mannose glycans with up to 9 mannose residues 202 ( Fig. 1C, table S2 ). 3D modelling revealed that the oligo-mannose glycans on N234 203 are accessible for hCD209 binding on all 3 monomers comprising the trimeric Spike 204 structures. Our analysis revealed a remarkable specificity of both, human CLEC4G 213 and mouse Clec4g, exclusively for N-glycans with an unsubstituted GlcNAcβ-214 1,2Manα-1,3Man arm (Fig. 5A, Fig. S6A , B, and Table S4 ). In addition, our analysis 215 revealed that mouse CD209c exhibits overlapping ligand specificities with murine 216 Clec4g and human CLEC4G, which is in fact distinct from the known binding profile of 217 human CD209. However, unlike Clec4g, CD209c recognized all N-glycan structures 218 that displayed terminal unsubstituted GlcNAc residues, independently of the position 219 in the glycan antennae (Fig. 5A, Fig. S6C and Table S4 ). The N-glycan at N343, 220 located within the RBD, is the glycosylation site most abundantly decorated with 221 terminal GlcNAc in Spike (Fig. 1C, table S2 ), constituting the candidate binding site 222 for murine CD209c and murine and human CLEC4G. 223 The terminal GlcNAc glycans on position N343 are accessible for hCLEC4G binding 225 on all 3 Spike monomers, but in contrast to hCD209, hCLEC4G binding interferes with 226 the ACE2/RBD interaction (Fig. 5B, fig. S5C , D). Since murine Clec4g and murine 227 CD209c show strongly overlapping ligand specificities to hCLEC4G, we next modelled 228 binding of these two lectins to the N343 glycan site. As predicted from our data, both 229 murine Clec4g and murine CD209c indeed interfere with the ACE2/RBD interaction 230 S5E ). Thus, whereas hCD209 is not predicted to directly affect ACE2/RBD 231 binding, murine Clec4g, murine CD209c and human CLEC4G binding to the N343 232 glycan impedes Spike binding to ACE2. 233 234 To test our structural models experimentally, we assessed whether these lectins could 236 interfere with Spike binding to the surface of Vero E6 cells, a frequently used SARS-237 CoV-2 infection model (Monteil et al., 2020) . To determine this, we set-up an AFM 238 based method, measuring spike binding activity on Vero E6 cells. Strikingly, as 239 predicted by the structural modelling, we found that hCLEC4G, but not hCD209, 240 significantly interfered with the binding of trimeric Spike to the Vero E6 cell surface 241 (Fig. 6A) . Similarly, mouse Clec4g, and importantly also murine CD209c, albeit to a 242 lesser extent, interfered with Spike binding to Vero E6 cells (Fig. 6B ). Finally, we tested 243 the ability of these lectins to reduce the infectivity of SARS-CoV-2. In accordance with 244 our model, murine Clec4g and murine CD209c significantly reduced SARS-CoV-2 245 infection of Vero E6 cells (Fig. 6C) . Finally, hCLEC4G also significantly reduced 246 SARS-CoV-2 infection of Vero E6 cells (Fig.6D) . These data uncover that the lectins 247 CLEC4G and CD209c can interfere with SARS-CoV-2 infections. 248 249 Here we report the results from unbiased screening of a comprehensive mammalian 251 lectin library for potent SARS-CoV-2 Spike binding, identifying mouse CD209c and 252 Clec4g, as well as their human homologs hCD209 and hCLEC4G, as N-glycan 253 dependent Spike receptors. hCD209 has been identified as candidate receptor for 254 SARS-CoV-2 by other groups, and other lectins have been also implicated in cellular 255 interactions with Spike (Gao et al., 2020; Thépaut et al., 2020) . CLEC4G has been 256 reported to associate with SARS-CoV (Gramberg et al., 2005 ), but has not been 257 implicated in SARS-CoV-2 infections. High-speed atomic force microscopy allowed us 258 to directly observe Spike/lectin interactions in real time. Our high-speed AFM data 259 showed that Spike/CLEC4G form more rigid clusters with lower conformational 260 flexibility as compared to the Spike/CD209 complexes in equilibrium conditions. This 261 is in accordance with faster association rates and shorter dissociation paths of 262 CLEC4G as compared to CD209. The experimentally observed association of 3-4 263 CLEC4G molecules with one molecule of the trimeric spike indicates the formation of 264 high affinity bonds to 1-2 glycosylation sites per monomeric subunit of the trimeric 265 Since glycosylation is not a template driven process, but rather depends on the 267 coordinated action of many glycosyltransferases and glycosidases (Stanley et al., 268 2015) , each glycosylation site can -within some boundaries -carry a range of glycans. 269 As a consequence, the 3 monomers of Spike can harbor different glycans on the same 270 glycosylation site. We identified N343 as the one glycosylation site that is almost 271 exclusively covered with GlcNAc terminated glycans, the ligands of human CLEC4G 272 and mouse Clec4g as well as, based on our new data, mouse CD209c. Given 273 localization of N343 within the RBD, we hypothesized that CLEC4G and mCD209c 274 binding interferes with the RBD-ACE2 interaction. Indeed, we found that murine 275 Clec4g and human CLEC4G, acting as a multi-valent effective inhibitor (KI ~ 35 -70 276 nM), can functionally impede with Spike binding to host cell membranes, thereby 277 providing a rationale how this lectin can affect SARS-CoV-2 infections. In support of 278 our data, it has recently been reported that a N343 glycosylation mutant exhibits 279 reduced infectivity using pseudo-typed viruses . 280 As for murine CD209c, our atomic force microscopy data indicate that CD209c 282 engages in a larger number of interactions per trimeric Spike (~ 5.2), presumably 283 because mCD209c binds to a greater variety of GlcNAc-linkages than Clec4g. This 284 more promiscuous glycan binding of mCD209c might also explain less, albeit 285 significant, inhibition of Spike binding to VeroE6 surface as compared to human and 286 mouse CLEC4G. Interestingly, the efficiency of inhibiting SARS-CoV-2 infection 287 between murine and human CLEC4G and mCD209c remained comparable. As such, 288 the multi-valent binding of CD209c may block SARS-CoV-2 infection not only through 289 direct interference with ACE2 binding, but possibly also via affecting conformational 290 Spike structures or proteolytic cleavage. Of note, while human and mouse CLEC4G 291 as well as mouse CD209c can interfere with RBD-ACE2 binding, human CD209 does 292 apparently not associate with glycans near the RBD and hence does not block Spike 293 binding to cells. This is in agreement to its proposed high affinity oligo-mannosidic 294 ligands, presented at N234, which is localized at a distance to the RBD-ACE2 295 interface. substrate. Determined spring constants ranged from 0.008 to 0.015 N/m. Force-557 distance curves were acquired by recording at least 1000 curves with vertical sweep 558 rates between 0.5 and 10 Hz at a z-range of typically 500 -1000 nm (resulting in 559 loading rates from 10 to 10,000 pN/s), using a commercial AFM (5500, Agilent 560 Technologies, USA). The relationship between experimentally measured unbinding 561 forces and parameters from the interaction potential were described by the kinetic 562 models of Bell (Bell, 1978) and Evans and Ritchie (Evans and Ritchie, 1997) . In 563 addition, multiple parallel bond formation was calculated by the Williams model 564 Vero E6 cells were grown on culture dishes using DMEM containing 10% FBS, 500 600 units/mL penicillin and 100 µg/mL streptomycin, at 37°C with 5% CO2. For AFM 601 measurements, the cell density was adjusted to about 10-30% confluency. Before the 602 measurements, the growth medium was exchanged to a physiological HEPES buffer 603 containing 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, and 10 mM HEPES 604 (pH 7.4). Lectins were added at the indicated concentrations. Using a full-length Spike 605 trimer anchored to an AFM cantilever (described above), force-distance curves were 606 Table S3 . ELISA screen of the lectin-Fc library against SARS-CoV-2 Spike, RBD 1146 and hrsACE2 1147 Results from the ELISA screens of the lectin-Fc library against indicated targets. Data 1148 displayed per lectin is mean and standard deviation (SD) (n=2). SD=NA indicates that 1149 mean was calculated from a single replicate only. 1150 Probe: FAM-TTCTGACCTGAAGGCTCTGCGCG-MGB Acknowledgements: We thank all members of the Penninger laboratory for helpful 704 discussions and technical support. Moreover, we thank all members of the Molecular 705 United States) for providing 707 the constructs used for production of recombinant Spike and RBD. Purified Spike and 708 RBD as well as transfection-grade pCAGGS plasmids were obtained from the reagent 709 repository of the BOKU COVID-19 Initiative. The authors thank Daniel Maresch 710 (BOKU Core Facility Mass Spectrometry) for assistance with glycan analysis 3A and S1A created with BioRender.com. J.M.P. and the research leading to these 712 results has received funding from the T. von Zastrow foundation, the FWF Wittgenstein 713 award (Z 271-B19), the Austrian Academy of Sciences, the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101005026 Canada 150 Research Chairs Program F18-01336 as well as the Canadian Institutes 716 of Health Research COVID-19 grants F20-02343 and F20-02015. D.H. is supported 717 by the T. von Zastrow foundation, S.M. is funded by the European Union's Horizon 718 2020 research and innovation programme under the Marie Sklodowska-Curie grant 719 agreement No 841319. We further acknowledge financial support from the Austrian 720 National Foundation for Research O), from the FWF projects V584 the WWTF grant LS19-029 the ÖAW fellowship STIP13202002 (L.H.), and the European A serological assay to detect SARS-CoV-2 seroconversion in humans Cutting edge: carbohydrate profiling 756 identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing 757 nonintegrin on dendritic cells Models for the specific adhesion of cells to cells Synthesis and microarray-assisted binding studies of core xylose and 762 fucose containing N-glycans The pathogen 765 receptor liver and lymph node sinusoidal endotelial cell C-type lectin is expressed in 766 human Kupffer cells and regulated by PU The DC-SIGN-related lectin LSECtin mediates antigen capture 770 and pathogen binding by human myeloid cells High-level and high-throughput 772 recombinant protein production by transient transfection of suspension-growing 773 human 293-EBNA1 cells Dynamic strength of molecular adhesion bonds SARS-CoV-2 Spike Protein Interacts 778 with Multiple Innate Immune Receptors The physiological role of DC-SIGN: a 780 tale of mice and men LSECtin interacts with 783 filovirus glycoproteins and the spike protein of SARS coronavirus Structural basis for distinct ligand-binding and 787 targeting properties of the receptors DC-SIGN and DC-SIGNR Detection and localization of individual antibody-antigen recognition events 791 by atomic force microscopy SARS-CoV-2 Cell 794 Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven 795 Structures and distributions of SARS-CoV-2 798 spike proteins on intact virions Immunological functions of liver sinusoidal 800 endothelial cells Video imaging of 802 walking myosin V by high-speed atomic force microscopy The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity 805 and Antigenicity. Cell Characterization of a novel C-type lectin-like gene, LSECtin: 808 demonstration of carbohydrate binding and expression in sinusoidal endothelial cells 809 of liver and lymph node Fcab-812 HER2 Interaction: a Menage a Trois. Lessons from X-Ray and Solution Studies CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble 817 Human ACE2 Curli mediate bacterial adhesion to fibronectin via 820 tensile multiple bonds Myeloid C-type lectin receptors in pathogen 822 recognition and host defense Mouse LSECtin as a model for a human Ebola virus receptor A novel mechanism for LSECtin binding to Ebola virus 828 surface glycoprotein through truncated glycans IgGs are made for walking on 831 bacterial and viral surfaces Multiple receptors involved in human rhinovirus attachment 834 to live cells Cell 836 entry mechanisms of SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen 840 Production, and Test Setup N-Glycans DC/L-SIGN recognition of spike 847 glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a 848 glycomimetic antagonist Detailed Evidence 851 for an Unparalleled Interaction Mode between Calmodulin and Orai Proteins Modeling of Oligosaccharides within 854 Glycoproteins from Free-Energy Landscapes Bitter-sweet symphony: glycan-lectin interactions in virus biology Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein Site-862 specific glycan analysis of the SARS-CoV-2 spike Vulnerabilities in coronavirus glycan shields despite extensive glycosylation. Nat 866 Commun 11 Exploitation of 868 glycosylation in enveloped virus pathobiology SWISS-MODEL: 872 homology modelling of protein structures and complexes Analytical descriptions of dynamic force spectroscopy: 875 behaviour of multiple connections Structural basis for 877 the recognition of SARS-CoV-2 by full-length human ACE2 Nanomechanical 881 recognition measurements of individual DNA molecules reveal epigenetic 882 methylation patterns PNGase F only" denotes wells that were not coated with 914 the Spike protein. Results are shown as mean OD values  SD normalized to BSA 915 controls (N=3). (E) and (F) Surface plasmon resonance (SPR) analysis with 916 immobilized full-length trimeric Spike See Table 1 for kinetics values. (C) t-test with Holm-Sidak 918 correction for multiple comparisons. (D) One-way ANOVA with Tukey's multiple 919 comparisons 001; ns: not significant ANOVA with Dunett's multiple comparisons test with the mock-treated group Kinetic association (ka,1), kinetic disssociation (kd,1), and equlibrium dissociation 1007 (Kd,1) constants of the first binding step fitted from the bivalent analyte model, 1008 assuming two-step binding and dissociation of the lectins to adjacent immobilized 1009 Spike trimer binding sites under spontaneous thermodynamic energy barriers; no 1010 reasonable fit was obtained with the simple 1:1 binding model (data not shown) Kinetic off-rate constants (koff) and lengths of dissociation paths (x) of single lectin 1012 originating from force-induced unbinding in single molecule force spectroscopy 1013 (SMFS) experiments and computed using Evans's (Bell, 1978; Evans and Ritchie, 1014 1997) model, assuming a sharp single dissociation energy barrier Mutation frequency of N-glycan sites on SARS-CoV-2 Spike Among the 1273 amino acids of Spike the frequency of mutational amino acid 1029 conversion within N-glycan sequons is plotted again all other sites. (B) The mutation 1030 frequency of all 1273 amino acids of Spike is shown. N-glycan sequons as well as 1031 mutations harbored by the new variants B Student's T-test, *p < 0.05 ELISA assays to detect lectin binding Schematic representation of the ELISA protocol, consisting of coating with trimeric 1039 full-length Spike or the monomeric receptor binding domain (RBD) followed by 1040 sequential incubation with lectin-Fc fusion proteins and secondary The binding of lectin-Fc fusion proteins was quantified by peroxidase-1042 dependent substrate conversion, measured by optical density (OD) at 490nm and 1043 normalized against a BSA control. (B) ELISA screen of the lectin-Fc library against 1044 human recombinant soluble ACE2 (hrsACE2) trimer, highlighting positions where the lectin was bound in the previous frame. The 1102 blue dotted ellipses display low mobility regions. Color schemes indicate height in 1103 nanometers (nm) Structural modelling of lectin-Spike interactions The 1110 model shows the (A) Spike monomer 1 and (B) Spike monomer 2 glycan site N234 1111 (Oligomannose structure Man9 in red) bound to hCD209. (C) and (D) 3D structural 1112 modelling of glycosylated trimeric Spike (green with glycans in yellow) interacting with 1113 the CRD of hCLEC4g (cyan with Ca 2+ in orange monomer 1 and (B) monomer 2 glycan site N343 (complex type glycan with terminal 1115 GlcNAc in purple-blue) bound to hCLEC4g. (E) 3D structural modelling of glycosylated 1116 trimeric Spike (green with glycans in yellow) interacting with glycosylated human ACE2 1117 (purple with glycans in salmon). The CRD of mClec4g (cyan with Ca 2+ in orange) was 1118 modelled onto Spike monomer 3 glycan site N343 Structural superposition of mClec4g and ACE2 highlights 1120 steric incompatibility Glycan microarray results Binding of mClec4g, mCD209c and hCLEC4G to glycans spotted on the microarray Primary data from three independent microarray measurements are shown Glycan microarray replicates of mClec4g, mCD209c, and hCLEC4G Avg) and standard deviation (SD) of the relative 1153 fluorescence units (RFU) measured among 4 replicated spots (n = 4). The glycan 1154 structures of GL1 to GL144 are illustrated in Fig High speed AFM of single trimeric Spike visualizing the real-time interaction 1157 dynamics with mClec4g acquired at a rate of 153.6 ms/frame High speed AFM of single trimeric Spike visualizing the real-time interaction 1159 dynamics with mCD209c acquired at a rate of 303 ms/frame High speed AFM of single trimeric Spike visualizing the real-time interaction 1161 dynamics with hCLEC4G acquired at a rate of 303 ms/frame High speed AFM of single trimeric Spike visualizing the real-time interaction 1163 dynamics with hCD209 acquired at a rate of 303 ms/frame individually plotted versus the respective force loading rates (equal to the pulling speed 1055 times effective spring constant) to decipher the dissociation dynamics (Table 1)